D. Vaughn

发表

Molecular evolution of dengue type 2 virus in Thailand.

R. Rico-Hesse, L. Harrison, A. Nisalak, 1998, The American journal of tropical medicine and hygiene.

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.

A. Nisalak, D. Vaughn, S. Kalayanarooj, 2000, The Journal of infectious diseases.

Dengue: an escalating problem

D. Vaughn, R. Gibbons, 2002, BMJ : British Medical Journal.

Safety and efficacy of a recombinant hepatitis E vaccine.

D. Vaughn, S. Shrestha, A. Safary, 2007, The New England journal of medicine.

Structure and age of genetic diversity of dengue virus type 2 in Thailand.

Chonticha Klungthong, Edward C Holmes, E. Holmes, 2006, The Journal of general virology.

Impact of dengue virus infection on feeding behavior of Aedes aegypti.

D. Vaughn, K. Linthicum, K. Platt, 1997, The American journal of tropical medicine and hygiene.

Relative Efficacy of AS03-Adjuvanted Pandemic Influenza A(H1N1) Vaccine in Children: Results of a Controlled, Randomized Efficacy Trial

D. Vaughn, Ping Li, L. Fries, 2014, The Journal of infectious diseases.

Characterization of monoclonal antibodies to hepatitis E virus (HEV) capsid protein and identification of binding activity.

D. Vaughn, R. Kuschner, Junkun He, 2007, Journal of biomedical science.

Neurological manifestations of dengue infection

N. M. Dung, J. Farrar, D. Vaughn, 2000, The Lancet.

Spatial and temporal circulation of dengue virus serotypes: a prospective study of primary school children in Kamphaeng Phet, Thailand.

Alan L Rothman, Daniel H Libraty, Francis A Ennis, 2002, American journal of epidemiology.

Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand.

Alan L Rothman, Daniel H Libraty, Francis A Ennis, 2004, The Journal of infectious diseases.

Hemorrhagic fever in Cambodia is caused by dengue viruses: evidence for transmission of all four serotypes.

A. Nisalak, D. Vaughn, S. Nimmannitya, 1997, The Southeast Asian journal of tropical medicine and public health.

Heterologous Prime-Boost Vaccination Using an AS03B-Adjuvanted Influenza A(H5N1) Vaccine in Infants and Children <3 Years of Age

D. Vaughn, H. Marshall, R. Booy, 2014, The Journal of infectious diseases.

Partnerships for detecting emerging infectious diseases: Nepal and global influenza surveillance.

D. Vaughn, N. Cox, P. Kelley, 1998, Emerging infectious diseases.

Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization

G. Kang, M. Lipsitch, D. Vaughn, 2021, Vaccine.

Prospective Study To Determine Accuracy of Rapid Serological Assays for Diagnosis of Acute Dengue Virus Infection in Laos

A. Nisalak, D. Vaughn, P. Newton, 2007, Clinical and Vaccine Immunology.

Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion

D. Vaughn, A. Didierlaurent, N. Garçon, 2012, Expert review of vaccines.

Interferon alfa-2 a in Japanese encephalitis : a randomised double-blind placebo-controlled trial

N. M. Dung, J. Farrar, D. Vaughn, 2018 .

Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis.

N. M. Dung, A. Nisalak, D. Vaughn, 2002, Brain : a journal of neurology.

Rapid Diagnosis of Japanese Encephalitis by Using an Immunoglobulin M Dot Enzyme Immunoassay

N. M. Dung, A. Nisalak, D. Vaughn, 1998, Journal of Clinical Microbiology.

AS03B-Adjuvanted H5N1 Influenza Vaccine in Children 6 Months Through 17 Years of Age: A Phase 2/3 Randomized, Placebo-Controlled, Observer-Blinded Trial

D. Vaughn, B. Innis, Robert J. Jeanfreau, 2014, The Journal of infectious diseases.

Analysis of plasma viral RNA levels during acute dengue virus infection using quantitative competitor reverse transcription‐polymerase chain reaction

A. Nisalak, D. Vaughn, S. Kalayanarooj, 2001, Journal of medical virology.

Multicentre evaluation of dengue IgM dot enzyme immunoassay.

A. Nisalak, D. Vaughn, V. Vorndam, 1996, Clinical and diagnostic virology.

Development of a fluorogenic RT-PCR system for quantitative identification of dengue virus serotypes 1-4 using conserved and serotype-specific 3' noncoding sequences.

D. Vaughn, N. Kanesa-thasan, H. Houng, 2001, Journal of virological methods.

Long-Term Persistence of Cell-Mediated and Humoral Responses to A(H1N1)pdm09 Influenza Virus Vaccines and the Role of the AS03 Adjuvant System in Adults during Two Randomized Controlled Trials

D. Vaughn, G. Leroux-Roels, R. G. van der Most, 2017, Clinical and Vaccine Immunology.

Evidence that Rodents Are a Reservoir of Hepatitis E Virus for Humans in Nepal

D. Vaughn, K. Linthicum, R. M. Scott, 2002, Journal of Clinical Microbiology.

Infectious diseases investment decision evaluation algorithm: a quantitative algorithm for prioritization of naturally occurring infectious disease threats to the U.S. military.

D. Vaughn, W. N. Burnette, T. Palys, 2008, Military medicine.

Age-specific prevalence of hepatitis A antibody in Thai children.

D. Vaughn, S. Kalayanarooj, R. Snitbhan, 1995, The Southeast Asian journal of tropical medicine and public health.

High prevalence of hepatitis G viremia among kidney transplant patients in Thailand

D. Vaughn, B. Raengsakulrach, C. Klungthong, 1997, Journal of medical virology.

WHO R&D Blueprint novel Coronavirus COVID-19 Animal Models

P. Horby, D. Vaughn, S. Ellenberg, 2020 .

Causes of death and unintentional injury among schoolchildren in Thailand.

D. Vaughn, B. Innis, S. Suntayakorn, 1999, Southeast Asian Journal of Tropical Medicine and Public Health.

ASPECTS OF TROPICAL DISEASE Japanese encephalitis

N. M. Dung, D. Vaughn, T. Solomon, 2000 .

Characterization of dengue-2 virus binding to surfaces of mammalian and insect cells.

D. Vaughn, T. Endy, B. Thaisomboonsuk, 2005, The American journal of tropical medicine and hygiene.

Seeking Help: B Cells Adapting to Flu Variability

D. Vaughn, E. Hanon, R. G. van der Most, 2014, Science Translational Medicine.

Hepatitis E virus DNA vaccine elicits immunologic memory in mice.

D. Vaughn, B. Innis, R. Kuschner, 2001, Journal of biomedical science.

Hepatitis E Virus DNA Vaccine Elicits Immunologic Memory in Mice

D. Vaughn, B. Innis, R. Kuschner, 2001, Journal of Biomedical Science.

A Phase 1/2 Trial of a Tetravalent Live-Attenuated Dengue Vaccine in Flavivirus-Naive Thai Infants

A. Nisalak, D. Vaughn, Stephen J. Thomas, 2006 .

A randomized, controlled non-inferiority trial comparing A(H1N1)pmd09 vaccine antigen, with and without AS03 adjuvant system, co-administered or sequentially administered with an inactivated trivalent seasonal influenza vaccine

D. Vaughn, J. Langley, Ping Li, 2012, BMC Infectious Diseases.

A novel method for the preparation of large cDNA fragments from dengue-3 RNA genome by long RT-PCR amplification.

A. Nisalak, D. Vaughn, B. Innis, 2000, The Southeast Asian journal of tropical medicine and public health.

Rapid Detection of Adenovirus in Throat Swab Specimens by PCR during Respiratory Disease Outbreaks among Military Recruits

D. Vaughn, Jose L. Sanchez, B. Innis, 2003, Journal of Clinical Microbiology.

Large epidemic of adenovirus type 4 infection among military trainees: epidemiological, clinical, and laboratory studies.

D. Vaughn, B. Feighner, Jose L. Sanchez, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Responses to A(H1N1)pdm09 Influenza Vaccines in Participants Previously Vaccinated With Seasonal Influenza Vaccine: A Randomized, Observer-Blind, Controlled Study

D. Vaughn, Ping Li, R. G. van der Most, 2014, The Journal of infectious diseases.

The socioeconomic impact of hepatitis E in Nepal.

D. Vaughn, R. M. Scott, B. Innis, 1999, The American journal of tropical medicine and hygiene.

Role of U.S. military research programs in the development of U.S.-licensed vaccines for naturally occurring infectious diseases.

D. Vaughn, L. Kitchen, 2007, Vaccine.

Safety and Immunogenicity of an AS03B-Adjuvanted Inactivated Tetravalent Dengue Virus Vaccine Administered on Varying Schedules to Healthy U.S. Adults: A Phase 1/2 Randomized Study

D. Vaughn, Stephen J. Thomas, R. Paris, 2020, The American journal of tropical medicine and hygiene.

A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis.

D. Vaughn, R. Kuschner, N. Kanesa-thasan, 2007, Vaccine.

Relative Ef ﬁ cacy of AS03-Adjuvanted Pandemic In ﬂ uenza A(H1N1) Vaccine in Children: Results of a Controlled, Randomized Ef ﬁ cacy Trial

D. Vaughn, Ping Li, L. Fries, 2014 .

Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials

D. Vaughn, A. Madan, Ping Li, 2013, BMC Infectious Diseases.

Route of inoculation and mosquito vector exposure modulate dengue virus replication kinetics and immune responses in rhesus macaques

Gregory D. Gromowski, D. Vaughn, R. Christofferson, 2020, PLoS neglected tropical diseases.

Clinical and immunological risk factors for severe disease in Japanese encephalitis.

A. Nisalak, D. Vaughn, B. Innis, 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Mechanisms of hemorrhage in dengue without circulatory collapse.

A. Nisalak, D. Vaughn, S. Kalayanarooj, 2001, The American journal of tropical medicine and hygiene.

Evaluation of a Rapid Immunochromatographic Test for Diagnosis of Dengue Virus Infection

N. M. Dung, A. Nisalak, D. Vaughn, 1998, Journal of Clinical Microbiology.

Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in ten American volunteers.

D. Vaughn, S. Yoksan, B. Innis, 1996, Vaccine.

Rapid diagnosis of dengue viremia by reverse transcriptase-polymerase chain reaction using 3'-noncoding region universal primers.

A. Nisalak, D. Vaughn, S. Kalayanarooj, 1997, The American journal of tropical medicine and hygiene.

Viremia, fecal shedding, and IgM and IgG responses in patients with hepatitis E.

D. Vaughn, P. Cheung, B. Innis, 1995, The Journal of infectious diseases.

Relative Ef fi cacy of AS 03-Adjuvanted Pandemic In fl uenza A ( H 1 N 1 ) Vaccine in Children : Results of a Controlled , Randomized Ef fi cacy Trial

D. Vaughn, Ping Li, L. Fries, 2014 .

Impaired T cell proliferation in acute dengue infection.

D. Vaughn, S. Kalayanarooj, S. Green, 1999, Journal of immunology.

Evaluation of a primary course of H9N2 vaccine with or without AS03 adjuvant in adults: A phase I/II randomized trial.

D. Vaughn, A. Madan, B. Innis, 2017, Vaccine.

An observer-blind, randomized, multi-center trial assessing long-term safety and immunogenicity of AS03-adjuvanted or unadjuvanted H1N1/2009 influenza vaccines in children 10-17 years of age.

D. Vaughn, Ping Li, S. Roy-Ghanta, 2014, Vaccine.

Safety and long-term humoral immune response in adults after vaccination with an H1N1 2009 pandemic influenza vaccine with or without AS03 adjuvant.

D. Vaughn, Ping Li, L. Fries, 2012, The Journal of infectious diseases.

West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy

D. Vaughn, A. Pletnev, R. Putnak, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Transplacentally transferred maternal-infant antibodies to dengue virus.

A. Nisalak, D. Vaughn, T. Endy, 2003, The American journal of tropical medicine and hygiene.

A Comparative Study of Leptospirosis and Dengue in Thai Children

A. Nisalak, D. Vaughn, S. Kalayanarooj, 2007, PLoS neglected tropical diseases.

Cellular immune activation in children with acute dengue virus infections is modulated by apoptosis.

A. Nisalak, D. Vaughn, S. Kalayanarooj, 2006, The Journal of infectious diseases.

The persistently troublesome cough

D. Vaughn, S. Kalayanarooj, S. Green, 2001 .

US Military contributions to the global response to pandemic chikungunya.

D. Vaughn, Pamela J. Glass, F. Malinoski, 2012, Vaccine.

Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.

D. Vaughn, R. Karron, R. Chanock, 2001, The American journal of tropical medicine and hygiene.

Short Communication Comparative analysis reveals no consistent association between the secondary structure of the 39-untranslated region of dengue viruses and disease syndrome

E. Holmes, D. Vaughn, S. Kalayanarooj, 2006 .

Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: How alterations in assay conditions impact performance.

A. Nisalak, D. Vaughn, S. Kalayanarooj, 2009, The American journal of tropical medicine and hygiene.

T CELL RECEPTOR V (cid:1) GENE USAGE IN THAI CHILDREN WITH DENGUE VIRUS INFECTION

D. Vaughn, S. Kalayanarooj, S. Green, 2001 .

Poliomyelitis-like illness due to Japanese encephalitis virus

N. M. Dung, A. Nisalak, D. Vaughn, 1998, The Lancet.

A model international partnership for community-based research on vaccine-preventable diseases: the Kamphaeng Phet-AFRIMS Virology Research Unit (KAVRU).

A. Nisalak, D. Vaughn, D. Burke, 2013, Vaccine.

NEUROLOGICAL ASPECTS OF TROPICAL DISEASE: Japanese encephalitis

N. M. Dung, D. Vaughn, T. Solomon, 2000 .

The epidemiology of Japanese encephalitis: prospects for prevention.

D. Vaughn, C. Hoke, 1992, Epidemiologic reviews.

Dengue Virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection.

A. Nisalak, D. Vaughn, S. Green, 2005, The Journal of infectious diseases.

Flaviviruses (Yellow Fever, Dengue, Dengue Hemorrhagic Fever, Japanese Encephalitis, West Nile Encephalitis, St. Louis Encephalitis, Tick-Borne Encephalitis)

A. Barrett, D. Vaughn, T. Solomon, 2010 .

Dengue epidemiology: virus epidemiology, ecology, and emergence.

D. Vaughn, D. Strickman, Stephen J. Thomas, 2003, Advances in virus research.

Detection of post-vaccination enhanced dengue virus infection in macaques: An improved model for early assessment of dengue vaccines

D. Vaughn, M. Malice, R. Marchevsky, 2019, PLoS pathogens.

Dengue Hemorrhagic Fever in Infants: Research Opportunities Ignored

S. Halstead, A. Nisalak, D. Vaughn, 2002, Emerging infectious diseases.

Antibody levels to hepatitis E virus in North Carolina swine workers, non-swine workers, swine, and murids.

D. Vaughn, J. Seriwatana, M. Stebbins, 2002, The American journal of tropical medicine and hygiene.

A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.

D. Vaughn, S. Lee, S. Lee, 2001, Vaccine.

Effect of high-dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus.

A. Nisalak, D. Vaughn, R. Johnson, 1992, The Journal of infectious diseases.

Rates of hepatitis E virus infection and disease among adolescents and adults in Kathmandu, Nepal.

D. Vaughn, B. Innis, M. P. Shrestha, 1997, The Journal of infectious diseases.

Hepatitis B virus infection in Thai children

D. Vaughn, B. Innis, R. Snitbhan, 2000, Tropical medicine & international health : TM & IH.

Hospital-based Diagnosis of Hemorrhagic Fever, Encephalitis, and Hepatitis in Cambodian Children

A. Nisalak, D. Vaughn, T. Endy, 2002, Emerging infectious diseases.

Detection of hepatitis E virus infections among domestic swine in the Kathmandu Valley of Nepal.

D. Vaughn, B. Innis, M. P. Shrestha, 1995, The American journal of tropical medicine and hygiene.

Respiratory viruses and influenza-like illness: Epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample

D. Vaughn, Ping Li, E. Lazcano-Ponce, 2016, Journal of Infection.

Rapid type-specific diagnosis of adenovirus type 4 infection using a hexon-based quantitative fluorogenic PCR.

D. Vaughn, Jose L. Sanchez, H. Houng, 2002, Diagnostic microbiology and infectious disease.

Scientific rationale for developing potent RBD-based vaccines targeting COVID-19

D. Vaughn, K. Makar, H. Kleanthous, 2021, npj Vaccines.

Detection of Specific Antibodies in Saliva during Dengue Infection

A. Nisalak, D. Vaughn, J. Aaskov, 1998, Journal of Clinical Microbiology.

Diagnosis of Dengue Virus Infections

A. Nisalak, D. Vaughn, T. Endy, 2008 .

Development and evaluation of an efficient 3′-noncoding region based SARS coronavirus (SARS-CoV) RT-PCR assay for detection of SARS-CoV infections

D. Vaughn, D. Norwood, H. Houng, 2004, Journal of Virological Methods.

TNF and LTA gene, allele, and extended HLA haplotype associations with severe dengue virus infection in ethnic Thais.

D. Vaughn, S. Kalayanarooj, S. Green, 2009, The Journal of infectious diseases.

Tumor necrosis factor ( TNF ) and lymphotoxin-alpha ( LTA ) gene , allele , and extended HLA haplotype associations with severe dengue virus infection in ethnic Thais

Green, D. Vaughn, A. Rothman, 2009 .

Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections.

N. M. Dung, A. Nisalak, D. Vaughn, 1999, The American journal of tropical medicine and hygiene.

Chapter 19 – Dengue

D. Vaughn, A. Durbin, S. Whitehead, 2009 .

High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever.

A. Nisalak, D. Vaughn, S. Kalayanarooj, 2002, Journal of Infectious Diseases.

Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period.

E. Holmes, A. Nisalak, D. Vaughn, 2002, Virology.

Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999.

Donald S Burke, A. Nisalak, D. Vaughn, 2003, The American journal of tropical medicine and hygiene.

Evidence that Rodents Are a Reservoir of Hepatitis E Virus for Humans in Nepal

D. Vaughn, K. Linthicum, R. M. Scott, 2006, Journal of Clinical Microbiology.

Comparison of PanBio Dengue Duo Enzyme-Linked Immunosorbent Assay (ELISA) and MRL Dengue Fever Virus Immunoglobulin M Capture ELISA for Diagnosis of Dengue Virus Infections in Southeast Asia

N. M. Dung, A. Nisalak, D. Vaughn, 1999, Clinical Diagnostic Laboratory Immunology.

Acute jaundice in Vientiane, Lao People's Democratic Republic.

D. Vaughn, K. Hyams, M. Putri, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of PanBio Dengue Duo IgM and IgG capture ELISA and venture technologies dengue IgM and IgG dot blot.

N. M. Dung, A. Nisalak, D. Vaughn, 2000, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus.

D. Vaughn, B. Innis, S. Tsarev, 2000, Vaccine.

Comparative analysis reveals no consistent association between the secondary structure of the 3'-untranslated region of dengue viruses and disease syndrome.

E. Holmes, D. Vaughn, S. Kalayanarooj, 2006, The Journal of general virology.

Dengue Virus Structural Differences That Correlate with Pathogenesis

R. Rico-Hesse, D. Vaughn, R. Salas, 1999, Journal of Virology.

Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections.

A. Nisalak, D. Vaughn, S. Kalayanarooj, 2002, The Journal of infectious diseases.

Etiology of interepidemic periods of mosquito-borne disease.

S I Hay, Monica F. Myers, D J Rogers, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study

A. Nisalak, D. Vaughn, S. Green, 2007, The Lancet.

Early clinical and laboratory indicators of acute dengue illness.

A. Nisalak, D. Vaughn, S. Kalayanarooj, 1997, The Journal of infectious diseases.

Use of Recombinant Envelope Proteins for Serological Diagnosis of Dengue Virus Infection in an Immunochromatographic Assay

A. Nisalak, D. Vaughn, S. Kalayanarooj, 2001, Clinical Diagnostic Laboratory Immunology.

Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans.

E. Konishi, D. Vaughn, P. Mason, 2000, Vaccine.

TT virus infection in acute non-A to E hepatitis in northern Thailand.

D. Vaughn, S. Suntayakorn, T. Endy, 2001, The Southeast Asian journal of tropical medicine and public health.

Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial

N. M. Dung, J. Farrar, D. Vaughn, 2003, The Lancet.

Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand.

Alan L Rothman, Daniel H Libraty, Francis A Ennis, 2002, American journal of epidemiology.

Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity.

A. Nisalak, D. Vaughn, S. Kalayanarooj, 1999, The Journal of infectious diseases.

Dengue 3 virus distribution in the mosquito Aedes aegyptl: an immunocytochemical study

D. Vaughn, K. Linthicum, K. Platt, 1996, Medical and veterinary entomology.

Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections.

D. Vaughn, T. Solomon, 2002, Current topics in microbiology and immunology.

Evaluation of a rapid quantitative diagnostic test for adenovirus type 4.

D. Vaughn, J. Gaydos, John T Connors, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Production of lethal infection that resembles fatal human disease by intranasal inoculation of macaques with Japanese encephalitis virus.

D. Vaughn, B. Innis, B. Raengsakulrach, 1999, The American journal of tropical medicine and hygiene.

HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais.

A. Nisalak, D. Vaughn, S. Kalayanarooj, 2002, Tissue antigens.

Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever.

A. Nisalak, D. Vaughn, S. Kalayanarooj, 1999, The Journal of infectious diseases.

T Cell Responses to an HLA-B*07-Restricted Epitope on the Dengue NS3 Protein Correlate with Disease Severity1

A. Nisalak, D. Vaughn, S. Kalayanarooj, 2002, The Journal of Immunology.

Predominance of HLA-Restricted Cytotoxic T-Lymphocyte Responses to Serotype-Cross-Reactive Epitopes on Nonstructural Proteins following Natural Secondary Dengue Virus Infection

D. Vaughn, S. Kalayanarooj, S. Green, 1998, Journal of Virology.

Disease Severity Epitope on the Dengue NS 3 Protein Correlate T Cell Responses to an HLA-B * 07-Restricted

A. Nisalak, D. Vaughn, S. Green, 2002 .

Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine.

D. Vaughn, R. Edelman, S. Wasserman, 2003, The American journal of tropical medicine and hygiene.

Dengue serotypes 2 and 3 in US forces In Somalia

D. Vaughn, A. Magill, N. Kanesa-thasan, 1994, The Lancet.

Short report: an outbreak of Japanese encephalitis in Kathmandu, Nepal.

A. Nisalak, D. Vaughn, R. M. Scott, 1997, The American journal of tropical medicine and hygiene.

Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: Pooled analysis of 28 clinical trials

D. Vaughn, Ping Li, Harry Seifert, 2014, Human vaccines & immunotherapeutics.

Clinical and Epidemiological Relevance of Quantitating Hepatitis E Virus-Specific Immunoglobulin M

D. Vaughn, R. M. Scott, B. Innis, 2002, Clinical and Vaccine Immunology.

Quantitation of Immunoglobulin to Hepatitis E Virus by Enzyme Immunoassay

D. Vaughn, R. M. Scott, B. Innis, 2002, Clinical and Vaccine Immunology.

Association of hepatitis E virus with an outbreak of hepatitis at a military training camp in Nepal

D. Vaughn, B. Innis, M. P. Shrestha, 1998, Journal of medical virology.

Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes.

D. Vaughn, B. Innis, R. Putnak, 2003, The American journal of tropical medicine and hygiene.

Role of US military research programs in the development of US Food and Drug Administration--approved antimalarial drugs.

D. Vaughn, L. Kitchen, David W Vaughn, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety, immunogenicity, and protective efficacy of NYVAC-JEV and ALVAC-JEV recombinant Japanese encephalitis vaccines in rhesus monkeys.

A. Nisalak, D. Vaughn, B. Innis, 1999, The American journal of tropical medicine and hygiene.

An intranasal challenge model for testing Japanese encephalitis vaccines in rhesus monkeys.

A. Nisalak, D. Vaughn, B. Innis, 1999, The American journal of tropical medicine and hygiene.

Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers.

D. Vaughn, J. Saluzzo, B. Innis, 2001, Vaccine.

Characterization of Antibody Responses to Combinations of a Dengue Virus Type 2 DNA Vaccine and Two Dengue Virus Type 2 Protein Vaccines in Rhesus Macaques

D. Vaughn, K. Porter, C. Hayes, 2006, Journal of Virology.

An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model.

D. Vaughn, D. Clements, T. Humphreys, 2005, Vaccine.

Dengue virus-specific memory T cell responses in human volunteers receiving a live attenuated dengue virus type 2 candidate vaccine.

D. Vaughn, F. Ennis, S. Yoksan, 1994, Journal of Infectious Diseases.

The comparative accuracy of 8 commercial rapid immunochromatographic assays for the diagnosis of acute dengue virus infection.

A. Nisalak, D. Vaughn, P. Newton, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevalence and Incidence of Respiratory Syncytial Virus and Other Respiratory Viral Infections in Children Aged 6 Months to 10 Years With Influenza-like Illness Enrolled in a Randomized Trial

D. Vaughn, Ping Li, E. Lazcano-Ponce, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Dengue in the early febrile phase: viremia and antibody responses.

A. Nisalak, D. Vaughn, S. Kalayanarooj, 1997, The Journal of infectious diseases.

Quantitative relationship between oral temperature and severity of illness following inoculation with candidate attenuated dengue virus vaccines.

P. Mackowiak, D. Vaughn, C. Tacket, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials

D. Vaughn, A. Lindstrand, J. Richardus, 2015, The Pediatric infectious disease journal.

Dengue hemorrhagic fever: the sensitivity and specificity of the world health organization definition for identification of severe cases of dengue in Thailand, 1994-2005.

Alan L Rothman, Daniel H Libraty, Francis A Ennis, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities—workshop report

D. Vaughn, K. Bok, D. Wolfe, 2023, npj Vaccines.

Immunogenicity and safety of AS03A-adjuvanted H5N1 influenza vaccine prepared from bulk antigen after stockpiling for 4 years.

D. Vaughn, Ping Li, P. Izurieta, 2015, Vaccine.

Evaluation of a dipstick enzyme-linked immunosorbent assay for detection of antibodies to dengue virus

A. Nisalak, D. Vaughn, K. Porter, 1997, Clinical and diagnostic laboratory immunology.

Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences.

Richard G Jarman, A. Nisalak, D. Vaughn, 2007, The American journal of tropical medicine and hygiene.

Blood group AB is associated with increased risk for severe dengue disease in secondary infections.

A. Nisalak, D. Vaughn, S. Kalayanarooj, 2007, The Journal of infectious diseases.

Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus-naive infants.

A. Nisalak, D. Vaughn, Stephen J. Thomas, 2008, The American journal of tropical medicine and hygiene.

Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults

D. Vaughn, Stephen J. Thomas, R. Edelman, 2009, Human vaccines.

Scientific consultation on immunological correlates of protection induced by dengue vaccines report from a meeting held at the World Health Organization 17-18 November 2005.

A. Barrett, D. Vaughn, J. Hombach, 2007, Vaccine.

Phase 1 studies of Walter Reed Army Institute of Research candidate attenuated dengue vaccines: selection of safe and immunogenic monovalent vaccines.

D. Vaughn, C. Tacket, R. Edelman, 2003, The American journal of tropical medicine and hygiene.

A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans.

D. Vaughn, C. Tacket, R. Edelman, 1994, The Journal of infectious diseases.

Evaluation of dengue virus strains for human challenge studies.

D. Vaughn, J. Statler, B. Innis, 2014, Vaccine.

Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccines.

D. Vaughn, Stephen J. Thomas, J. Statler, 2013, The Journal of infectious diseases.

Transplacental Chikungunya Virus Antibody Kinetics, Thailand

A. Nisalak, D. Vaughn, T. Endy, 2006, Emerging infectious diseases.

MATERNAL-INFANT ANTIBODIES TO DENGUE VIRUS

D. Vaughn, T. Endy, A. Kerdpanich, 2003 .

Cytokine gene expression and protein production in peripheral blood mononuclear cells of children with acute dengue virus infections

D. Vaughn, S. Kalayanarooj, S. Green, 2002, Journal of medical virology.

Recognition of synthetic oligopeptides from nonstructural proteins NS1 and NS3 of dengue-4 virus by sera from dengue virus-infected children.

D. Vaughn, R. D. del Ángel, G. Garcia, 1997, The American journal of tropical medicine and hygiene.

The study transplacental chikungunya virus antibody kinetics, Thailand.

A. Nisalak, D. Vaughn, T. Endy, 2006 .

Invited commentary: Dengue lessons from Cuba.

D. Vaughn, 2000, American journal of epidemiology.

Comparison of four reverse transcription-polymerase chain reaction procedures for the detection of dengue virus in clinical specimens.

A. Nisalak, D. Vaughn, S. Kalayanarooj, 2002, Journal of virological methods.

Comparison of Two Rapid Diagnostic Assays for Detection of Immunoglobulin M Antibodies to Dengue Virus

D. Vaughn, G. Murphy, C. Hayes, 2000, Clinical Diagnostic Laboratory Immunology.

Serological investigation of a febrile outbreak in Delhi, India, using a rapid immunochromatographic test.

D. Vaughn, 1998, Journal of clinical microbiology.

Modification of dengue virus strains by passage in primary dog kidney cells: preparation of candidate vaccines and immunization of monkeys.

D. Vaughn, B. Innis, E. Henchal, 2003, The American journal of tropical medicine and hygiene.

Vaccine Strategies to Prevent Dengue

D. Vaughn, R. Edelman, S. Whitehead, 2009 .

Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren.

A. Nisalak, D. Vaughn, S. Green, 2002, The Journal of infectious diseases.

Hepatitis E virus in Nepal: similarities with the Burmese and Indian variants.

D. Vaughn, V. Gouvea, B. Innis, 1997, Virus research.

Rapid Immunization Against H5N1: A Randomized Trial Evaluating Homologous and Cross-Reactive Immune Responses to AS03A-Adjuvanted Vaccination in Adults

D. Vaughn, A. Madan, Ping Li, 2011, The Journal of infectious diseases.

Dose-Sparing H5N1 A/Indonesia/05/2005 Pre-pandemic Influenza Vaccine in Adults and Elderly Adults: A Phase III, Placebo-Controlled, Randomized Study

D. Vaughn, J. Langley, Ping Li, 2011, The Journal of infectious diseases.

Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: An observer-blind, randomized trial☆☆

William H. Yang, D. Vaughn, Ping Li, 2013, Vaccine.

Safety and Immunogenicity of Different Formulations of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico: Final Results after 3 Years of Follow-Up from a Randomized, Placebo-Controlled Phase I Study

D. Vaughn, Stephen J. Thomas, R. Paris, 2020, The American journal of tropical medicine and hygiene.

Dengue virus-specific human CD4+ T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: bulk culture proliferation, clonal analysis, and precursor frequency determination

D. Vaughn, S. Green, F. Ennis, 1993, Journal of virology.

Randomized, Multicenter Trial of a Single Dose of AS03-adjuvanted or Unadjuvanted H1N1 2009 Pandemic Influenza Vaccine in Children 6 Months to <9 Years of Age: Safety and Immunogenicity

D. Vaughn, A. Madan, J. Langley, 2012, The Pediatric infectious disease journal.

Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.

A. Nisalak, D. Vaughn, Stephen J. Thomas, 2006, The Journal of infectious diseases.

Non‐neutralizing antibody responses following A(H1N1)pdm09 influenza vaccination with or without AS03 adjuvant system

D. Vaughn, F. Ennis, Ping Li, 2020, Influenza and other respiratory viruses.

Evaluation of immune response following one dose of an AS03A-adjuvanted H1N1 2009 pandemic influenza vaccine in Japanese adults 65 years of age or older

H. Ikematsu, D. Vaughn, A. Madan, 2012, Human vaccines & immunotherapeutics.

Early CD 69 Expression on Peripheral Blood Lymphocytes from Children with Dengue Hemorrhagic Fever

A. Nisalak, D. Vaughn, S. Kalayanarooj, 1999 .

Dengue Virus (DENV) Neutralizing Antibody Kinetics in Children After Symptomatic Primary and Postprimary DENV Infection.

D. Cummings, A. Nisalak, D. Vaughn, 2016, The Journal of infectious diseases.

Immunological priming induced by a two-dose series of H5N1 influenza antigen, administered alone or in combination with two different formulations of AS03 adjuvant in adults: results of a randomised single heterologous booster dose study at 15 months.

D. Vaughn, J. Langley, Ping Li, 2011, Vaccine.

Immunological priming induced by a two-dose series of H5N1 influenza antigen, administered alone or in combination with two different formulations of AS03 adjuvant in adults: Results of a randomised single heterologous booster dose study at 15 months.

D. Vaughn, J. Langley, Ping Li, 2013, Vaccine.

and post-primary dengue virus infections

A. Nisalak, D. Vaughn, S. Kalayanarooj, 2015 .

T cell receptor Vbeta gene usage in Thai children with dengue virus infection.

D. Vaughn, S. Kalayanarooj, S. Green, 2001, The American journal of tropical medicine and hygiene.

T cell receptor Vβ gene usage in Thai children with dengue virus infection

D. Vaughn, S. Kalayanarooj, S. Green, 2001 .

Vaccines Against Human Hookworm Disease

S. Hoffman, D. Vaughn, R. Brunham, 2004 .

A waterborne outbreak of hepatitis E virus transmission in southwestern Vietnam.

D. Vaughn, T. Vu, K. Hyams, 1996, The American journal of tropical medicine and hygiene.

Herpes simplex virus type-2, cytomegalovirus and Epstein-Barr virus infection in acute non A to E hepatitis Thai patients.

D. Vaughn, P. Puthavathana, B. Raengsakulrach, 1997, Asian Pacific journal of allergy and immunology.

Hepatitis E antibody kinetics in Nepalese patients.

D. Vaughn, S. Shrestha, B. Innis, 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Safety and Efficacy of a Hepatitis E Virus Vaccine Conducted in Nepal

D. Vaughn, S. Shrestha, A. Safary, 2006 .